)
)
)
Jupiter Neurosciences (Nasdaq:JUNS)
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on developing therapies for neuroinflammation and central nervous system disorders. The Company’s lead clinical program is advancing through a Phase IIa trial in Parkinson’s disease. Jupiter is also commercializing Nugevia™, a consumer product built on its patented JOTROL™ technology platform designed to enhance resveratrol bioavailability. Jupiter’s dual-path strategy combines clinical development with commercial revenue generation.
Year Founded
2015
Lead Product in Development
JOTROL
Development Phase of Lead Product
Phase II
Number of Unlicensed Products Looking for Licensing
1
Exchange
Nasdaq
Ticker
JUNS
CEO/Top Company Official
Christer Rosén
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
